Revelation Biosciences Inc (NASDAQ:REVB)’s traded shares stood at 0.36 million during the last session, with the company’s beta value hitting 0.25. At the close of trading, the stock’s price was $0.40, to imply a decrease of -3.45% or -$0.01 in intraday trading. The REVB share’s 52-week high remains $25.26, putting it -6215.0% down since that peak but still an impressive 30.0% since price per share fell to its 52-week low of $0.28. The company has a valuation of $3.34M, with an average of 11.76 million shares in intraday trading volume over the past 10 days and average of 3.15 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Revelation Biosciences Inc (REVB), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give REVB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
After registering a -3.45% downside in the last session, Revelation Biosciences Inc (REVB) has traded red over the past five days. The 5-day price performance for the stock is -24.34%, and 14.97% over 30 days. With these gigs, the year-to-date price performance is -13.21%. Short interest in Revelation Biosciences Inc (NASDAQ:REVB) saw shorts transact 0.24 million shares and set a 0.1 days time to cover.
Revelation Biosciences Inc (REVB) estimates and forecasts
Looking at statistics comparing Revelation Biosciences Inc share performance against respective industry, we note that the company has outperformed competitors. Revelation Biosciences Inc (REVB) shares are -77.40% down over the last 6 months, with its year-to-date growth rate higher than industry average at 79.76% against 16.60%.
REVB Dividends
Revelation Biosciences Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Revelation Biosciences Inc insiders hold 0.03% of total outstanding shares, with institutional holders owning 11.37% of the shares at 11.37% float percentage. In total, 11.37% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Revelation Biosciences Inc (REVB) shares. Going by data provided on Nov 30, 2024 , Fidelity Extended Market Index Fund holds roughly 8.02 shares. This is just over 0.10% of the total shares, with a market valuation of $3209.0. Data from the same date shows that the other fund manager holds a little less at 2.94, or 0.04% of the shares, all valued at about 1177.0.
